{
    "fund_name": "Leverage Shares 5x Long Magnificent 7 ETP",
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": false,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "5x daily leverage",
        "Synthetic replication",
        "Collateralized structure",
        "High risk profile (Class 7/7)",
        "Short-term holding recommendation (1 day)",
        "Potential for compounding effect",
        "No capital protection",
        "Counterparty risk exposure"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex under MiFID II due to multiple factors: 1) It uses synthetic replication with derivatives (swaps) to achieve 5x daily leverage on the Solactive Magnificent 7 Index. 2) The product has a recommended holding period of just 1 day due to the compounding effect of daily leverage, which makes it unsuitable for long-term investors. 3) The risk profile is extremely high (Class 7/7), indicating significant potential for losses. 4) The product is collateralized, introducing counterparty risk. 5) The KIID explicitly states 'You are about to purchase a product that is not simple and may be difficult to understand,' which is a strong indicator of complexity under MiFID II. 6) The product is not UCITS-compliant, which often correlates with higher complexity. 7) The PRIIPs KID would likely contain a comprehension warning, further indicating complexity. While the fact sheet might provide additional operational details, the core characteristics from the KIID are sufficient to classify this as a complex product.",
    "confidence": 95,
    "counter_arguments": "One might argue that the product's daily liquidity and transparent benchmark make it less complex, but the extreme leverage, short-term holding requirement, and synthetic structure override these factors under MiFID II guidelines. The combination of these elements creates a product that requires sophisticated understanding and carries significant risks that typical retail investors may not fully comprehend.",
    "risk_level_assessment": "The product's risk level is extremely high (Class 7/7), which aligns with its complex classification. The potential for significant losses, compounding effects, and counterparty risks all contribute to this high-risk profile."
}